Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma

ABSTRACT: Introduction: Fractional exhaled nitric oxide is a simple, non-invasive measurement of airway inflammation with minimal discomfort to the patient and with results available within a few minutes. This study aimed to evaluate the cost-effectiveness of asthma management using fractional exhal...

Full description

Autores:
Buendía Rodríguez, Jefferson Antonio
Acuña Cordero, Ranniery
Rodríguez Martínez, Carlos Enrique
Tipo de recurso:
Article of investigation
Fecha de publicación:
2021
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/44933
Acceso en línea:
https://hdl.handle.net/10495/44933
Palabra clave:
Economía y Organizaciones para la Atención de la Salud
Health Care Economics and Organizations
Salud Pública
Public Health
Atención a la Salud
Delivery of Health Care
Asma
Asthma
Análisis Costo-Beneficio
Cost-Benefit Analysis
Prueba de Óxido Nítrico Exhalado Fraccionado
Fractional Exhaled Nitric Oxide Testing
https://id.nlm.nih.gov/mesh/D004472
https://id.nlm.nih.gov/mesh/D011634
https://id.nlm.nih.gov/mesh/D003695
https://id.nlm.nih.gov/mesh/D001249
https://id.nlm.nih.gov/mesh/D003362
https://id.nlm.nih.gov/mesh/D000089142
Rights
openAccess
License
https://creativecommons.org/licenses/by/4.0/
Description
Summary:ABSTRACT: Introduction: Fractional exhaled nitric oxide is a simple, non-invasive measurement of airway inflammation with minimal discomfort to the patient and with results available within a few minutes. This study aimed to evaluate the cost-effectiveness of asthma management using fractional exhaled nitric oxide monitoring in patients between 4 and 18 years of age. Methods: A Markov model was used to estimate the cost-utility of asthma management using fractional exhaled nitric oxide monitoring versus asthma management without using fractional exhaled nitric oxide monitoring (standard therapy) in patients between 4 and 18 years of age. Cost data were obtained from a retrospective study on asthma from a tertiary center, in Medellin, Colombia, while probabilities of the Markov model and utilities were obtained from the systematic review of published randomized clinical trials. The analysis was carried out from a societal perspective. Results: The model showed that fractional exhaled nitric oxide monitoring was associated with a lower total cost than standard therapy (US $1333 vs. US $1452 average cost per patient) and higher QALYs (0.93 vs. 0.92 average per patient). The probability that fractional exhaled nitric oxide monitoring provides a more cost-effective use of resources compared with standard therapy exceeds 99% for all willingness-to-pay thresholds. Conclusion: Asthma management using fractional exhaled nitric oxide monitoring was cost-effective for treating patients between 4 and 18 years of age with mild to moderate allergic asthma. Our study suggests evidence that could be used by decision-makers to improve clinical practice guidelines, but this should be replicated in different clinical settings.